Can gastro‑oesophageal reflux disease (GERD) cause palpitations, and what is the recommended evaluation and treatment?

GERD Can Cause Palpitations Through Cardiac Arrhythmias

Yes, GERD can cause palpitations, primarily through triggering premature ventricular contractions (PVCs) and atrial arrhythmias, and these symptoms often respond to aggressive acid suppression therapy. Recent case evidence demonstrates that PVCs associated with GERD occur predominantly after meals or alcohol intake and can be effectively controlled with proton pump inhibitors (PPIs) or potassium-competitive acid blockers (PCABs) 1.

Mechanism and Clinical Presentation

The relationship between GERD and palpitations appears to be mediated through:

• Postprandial and post-alcohol timing: PVCs occur exclusively during or after meals and alcohol consumption 1
• Position-dependent symptoms: Palpitations worsen when lying down, suggesting reflux-triggered arrhythmias 1
• Atrial arrhythmias: Atrial fibrillation symptoms can reduce with antireflux therapy 2

Important caveat: While older studies using simultaneous pH and Holter monitoring during physiologic reflux episodes found no relationship between reflux and heart rate changes 3, these studies may have missed the clinical scenarios where GERD-triggered arrhythmias actually occur (postprandial periods, severe reflux episodes).

Recommended Evaluation Approach

Initial Assessment

1. Cardiac evaluation first: Rule out primary cardiac causes of palpitations before attributing them to GERD
2. Look for temporal patterns: Document whether palpitations occur:
   • After meals or alcohol intake
   • When lying down
   • In association with typical GERD symptoms (heartburn, regurgitation)

Diagnostic Testing Strategy

If cardiac causes are excluded and GERD is suspected:

For patients WITH typical GERD symptoms (heartburn/regurgitation) plus palpitations:

• Start empirical PPI therapy without testing 4, 5
• No need for endoscopy or pH monitoring if symptoms respond 4

For patients WITHOUT typical GERD symptoms (palpitations as isolated extraesophageal manifestation):

• Consider objective testing before prolonged empirical therapy 6
• Ambulatory pH monitoring off acid suppression is preferred 6
• Combined 24-hour pH and Holter monitoring can demonstrate temporal correlation 2

Treatment Recommendations

First-Line Therapy

Initiate twice-daily PPI therapy for 4-8 weeks 7, 8, 5:

• Omeprazole 20-40 mg twice daily before meals, or equivalent PPI 7
• Twice-daily dosing is superior to once-daily for extraesophageal symptoms
• Treatment duration of at least 8 weeks is necessary 7

Alternative Agents

• PCAB (potassium-competitive acid blockers): May be more effective than antiarrhythmics in some cases 1
• H2 antagonists: Less effective than PPIs but can be added at night for breakthrough symptoms 7

Adjunctive Measures

• Eliminate reflux-worsening medications: Calcium channel blockers, nitrates, theophylline 7
• Lifestyle modifications 8:
  • Weight loss if overweight/obese
  • Elevate head of bed for nighttime symptoms
  • Avoid late meals and trigger foods (alcohol, coffee, fatty foods)

Monitoring Response

• Assess symptom-reflux correlation: Use wearable ECG monitoring to document PVC frequency before and after treatment 1
• Treatment success: Reduction in palpitation frequency correlating with acid suppression
• Duration: If effective, continue therapy; consider step-down after 8-12 weeks of symptom control

When to Escalate Care

Refer for advanced testing if:

• No response to 8-12 weeks of twice-daily PPI therapy 6
• Alarm symptoms develop (dysphagia, weight loss)
• Palpitations persist despite documented acid suppression

Consider antireflux surgery for:

• Carefully selected cases with documented GERD and refractory symptoms 7
• Requires preoperative pH monitoring, manometry, and exclusion of other causes 7

Critical Clinical Pearls

• Timing is diagnostic: PVCs occurring exclusively postprandially or after alcohol strongly suggest GERD etiology 1
• PCAB may outperform antiarrhythmics: In one case, PCAB controlled PVCs better than flecainide (0.01% vs 2.8% PVC burden) 1
• Don't assume all palpitations are cardiac: Consider GERD in the differential, especially with meal-related timing
• Aggressive acid suppression is key: Standard once-daily dosing may be insufficient for extraesophageal manifestations 7, 6